|
EC 5.4.3.2 (lysine 2,3-aminomutase) inhibitor
|
CHEBI_75190 |
|
|
thyroid gland
|
UBERON_0002046 |
[Either of paired structures located in the throat which develop from the ventral wall of the pharynx and excretes hormones involved in the morphological and functional changes during metamorphosis as well as influencing other tissues.[AAO]] |
|
Clostridium botulinum
|
NCBITaxon_1491 |
|
|
cytosol
|
GO_0005829 |
|
|
glycine receptor agonist
|
CHEBI_64589 |
|
|
uremic toxin
|
CHEBI_64584 |
|
|
STAT3 inhibitor
|
CHEBI_87183 |
|
|
glycine transporter 1 inhibitor
|
CHEBI_64588 |
|
|
gelator
|
CHEBI_51266 |
|
|
swelling agent
|
CHEBI_51267 |
|
|
oxidising agent
|
CHEBI_63248 |
|
|
reducing agent
|
CHEBI_63247 |
|
|
NMDA receptor agonist
|
CHEBI_64571 |
|
|
EC 2.1.2.1 (glycine hydroxymethyltransferase) inhibitor
|
CHEBI_64570 |
|
|
flour treatment agent
|
CHEBI_64577 |
|
|
drying control chemical additive
|
CHEBI_51268 |
|
|
colon carcinoma in situ
|
DOID_8826 |
|
|
intestine carcinoma in situ
|
DOID_9024 |
|
|
steatosis inducing agent
|
CHEBI_83609 |
|
|
THP-1 cell
|
CLO_0009348 |
|
